Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Levodopa and Carbidopa (Gastroenteral use)

EU orphan designation number: EU/3/01/035
Remark: A national marketing authorisation has been obtained under the name "Duodopa" on 18/11/2005.
Active ingredient: Levodopa and Carbidopa (Gastroenteral use)
Indication: Treatment of advanced idiopathic Parkinson's disease with severe motor fluctuations and not responding to oral treatment
Sponsor: AbbVie Ltd
Abbvie House, Vanwall Business Park, Vanwall Road, Maidenhead, Berkshire SL6 4UB, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
12/05/2001 Orphan designation EMEA/OD/052/00 (2001)1197 of 10/05/2001
16/03/2006 Transfer of orphan designation EMEA/OD/052/00/T/01 (2006)727 of 02/03/2006
21/01/2011 Change of name and/or address of sponsor
08/02/2013 Transfer of orphan designation EMA/OD/052/00/T/02 (2013)731 of 06/02/2013
18/11/2015 Removal of orphan designation from Community Register